# Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity

> **NCT05834062** · PHASE2 · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- Obesity, Adolescent

## Interventions

- **DRUG:** Qsymia and lifestyle management therapy
- **BEHAVIORAL:** Placebo and lifestyle management therapy

## Key facts

- **NCT ID:** NCT05834062
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-10-17
- **Primary completion:** 2026-08
- **Final completion:** 2027-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The project was not funded
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05834062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05834062, "Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05834062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*